Propanc Biopharma plans $100 million Ethereum purchase over 12 months
Tweet Send to a Friend
Propanc Biopharma Inc. (NASDAQ: PPCB) announced plans to acquire $100 million of Ethereum over the next 12 months as part ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
